LAUSR

Key Points Question Are there differences in survival and comorbidity burden among East, South, and Southeast Asian patients vs Native Hawaiian and other Pacific Islander patients with nonmetastatic cancer? Findings This cohort study among 5 955 550 patients found that while Asian patients with cancer had significantly superior survival compared with non-Hispanic White patients, Native Hawaiian and other Pacific Islander patients with most cancers did not. Unlike Asian patients, Native Hawaiian and other Pacific Islander patients with cancer had significantly higher comorbidity burden compared with non-Hispanic White patients. Meaning These findings suggest that data for Native Hawaiian and other Pacific Islander patients should not be aggregated with Asian patients, as this may mask Native Hawaiian and other Pacific Islander disparities with significant implications for health policy.